한글목차

재택 주입 요법 시장 규모는 2025년 209억 6,000만 달러에서 2026년부터 2034년까지 CAGR 7.17%로 성장하여 2034년에는 390억 9,000만 달러에 달할 것으로 예측됩니다.

의료 시스템이 환자의 집에서 편안하게 치료를 받을 수 있는 이점을 점점 더 많이 인식함에 따라 재택 주입 요법 시장은 수요가 급증하고 있습니다. 이러한 변화는 만성질환의 증가, 고령화, 입원 관련 비용의 증가에 의해 촉진되고 있습니다. 재택 주입 요법은 항생제, 화학요법, 통증 관리 등 필요한 치료를 받으면서도 병원 방문 횟수를 최소화할 수 있는 효과적인 대안이 될 수 있습니다. 홈케어의 편리함과 편안함은 환자와 의료진 모두에게 매력적이며, 이 시장은 크게 성장할 것으로 예상됩니다.

기술 혁신은 재택 수액 치료 환경을 크게 개선하고 있습니다. 휴대용 수액 장치와 스마트 기술 솔루션의 개발로 재택 치료의 안전성과 효율성이 향상되고 있습니다. 이러한 혁신을 통해 의료진은 원격으로 환자를 모니터링하고, 치료 프로토콜을 준수하고, 필요한 경우 적시에 개입할 수 있습니다. 또한, 원격의료 서비스의 통합으로 환자와 의료진 간의 소통이 원활해져 진료의 질이 더욱 향상되고 있습니다. 기술의 발전과 함께 환자 참여의 증가와 치료 결과의 개선에 힘입어 재택 주입 요법 시장은 확대될 것으로 예상됩니다.

또한, 환자 중심의 치료를 촉진하고 의료비 절감을 목표로 하는 정책으로 인해 재택 주입 요법에 대한 규제 환경이 더욱 우호적으로 변화하고 있습니다. 재택 치료를 우대하는 상환 모델이 발전함에 따라 의료 제공자가 재택 수액 서비스에 투자할 가능성이 높아지고 있습니다. 재택 치료의 장점에 대한 인식이 높아지고, 기술 발전과 지원적인 규제가 결합되면서 재택 수액 치료 시장은 향후 몇 년 동안 견조한 성장을 보일 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 재택 주입 요법 시장 : 제품 유형별

제5장 세계의 재택 주입 요법 시장 : 용도별

제6장 세계의 재택 주입 요법 시장 : 지역별

제7장 경쟁 구도

제8장 기업 개요

영문목차

The Home Infusion Therapy Market size is expected to reach USD 39.09 Billion in 2034 from USD 20.96 Billion (2025) growing at a CAGR of 7.17% during 2026-2034.

The home infusion therapy market is experiencing a surge in demand as healthcare systems increasingly recognize the benefits of delivering care in the comfort of patients' homes. This shift is driven by the growing prevalence of chronic diseases, the aging population, and the rising costs associated with hospital stays. Home infusion therapy offers a viable alternative, allowing patients to receive necessary treatments, such as antibiotics, chemotherapy, and pain management, while minimizing hospital visits. The convenience and comfort of home-based care are appealing to both patients and healthcare providers, positioning this market for substantial growth.

Technological advancements are significantly enhancing the home infusion therapy landscape. The development of portable infusion devices and smart technology solutions is improving the safety and efficiency of home-based treatments. These innovations enable healthcare professionals to monitor patients remotely, ensuring adherence to treatment protocols and timely interventions when necessary. Additionally, the integration of telehealth services is facilitating better communication between patients and healthcare providers, further enhancing the quality of care. As technology continues to evolve, the home infusion therapy market is expected to expand, driven by increased patient engagement and improved treatment outcomes.

Moreover, the regulatory environment is becoming more supportive of home infusion therapy, with policies aimed at promoting patient-centered care and reducing healthcare costs. As reimbursement models evolve to favor home-based treatments, healthcare providers are more likely to invest in home infusion services. The growing awareness of the benefits of home care, coupled with advancements in technology and supportive regulations, positions the home infusion therapy market for robust growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Infusion Pumps
• Intravenous Set
• IV Cannulas
• Needleless Connectors

By Application

• Chemotherapy
• Diabetes
• Hydration Therapy
• Pain Management
• Post-transplant Therapies
• Parenteral Nutrition Therapy
• Others

COMPANIES PROFILED

• Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical, CareCentrix Inc, Coram CVSspecialty infusion services, Option Care Health Inc, CVS Health, UnitedHealth Group Optum, McKesson Corporation, PharMerica Corporation, BioScrip Inc, MedicoRx Specialty Pharmacy, InfuSystem, Diplomat Pharmacy Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HOME INFUSION THERAPY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Intravenous Set Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. IV Cannulas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Needleless Connectors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HOME INFUSION THERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hydration Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Post-transplant Therapies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Parenteral Nutrition Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HOME INFUSION THERAPY MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HOME INFUSION THERAPY INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Baxter International Inc
  • 8.2.2 B. Braun Melsungen AG
  • 8.2.3 Fresenius Kabi AG
  • 8.2.4 Smiths Medical
  • 8.2.5 CareCentrix Inc
  • 8.2.6 Coram CVS/Specialty Infusion Services
  • 8.2.7 Option Care Health Inc
  • 8.2.8 CVS Health
  • 8.2.9 UnitedHealth Group (Optum)
  • 8.2.10 McKesson Corporation
  • 8.2.11 PharMerica Corporation
  • 8.2.12 BioScrip Inc
  • 8.2.13 MedicoRx Specialty Pharmacy
  • 8.2.14 InfuSystem
  • 8.2.15 Diplomat Pharmacy Inc